← Back to Newsroom

Furnetics Unlimited Ltd. today confirmed, in the aggregate form required by the Independent Ethics Board's charter, that the Board has declined its tenth proposed template class since the Board's constitution in June 2014. The corporation further confirms, as the charter's threshold-disclosure clause requires on the tenth cumulative declination, that seven of the ten proposals concerned prospective templates in the reptile clade.

No further particulars — of the proposals, of the principals who submitted them, of the dates of the individual votes, or of the reasoning by which the Board arrived at each decision — will be disclosed. The Board's charter, in the form ratified in November 2024 as its seventh revision, requires the aggregate publication now made and prohibits any specificity that would identify a proposal, its principal, or its intended clinical form.

“The Board is asked, from time to time, to consider proposed template classes that would extend the corporation's clinical offering. It is asked more often than the public record would suggest. That the count of what the Board has declined has now reached ten does not, in itself, describe the Board's disposition; it describes the willingness of scientists inside and outside the corporation to bring difficult proposals forward, which we regard as healthy. The point of the disclosure is that the count exists and that the count is not zero.”

— Priya Ravindran, General Counsel & Chief Privacy Officer

What the aggregate discloses, and what it does not

The disclosure is limited by the charter to three specific facts: the cumulative count of declined template classes since 2014; the count of those declinations that fall within any single taxonomic clade at or above the level of Class; and the fact that the threshold has been crossed. Nothing else about the individual proposals may be published, either at the time or in any subsequent document, except in a redacted form determined by the Board itself.

The seven-of-ten figure for the reptile clade is the only clade-level aggregate the current disclosure crosses the threshold for reporting. The remaining three declinations fall across more than one clade and cannot, under the charter, be further aggregated without approaching a level of specificity the charter is written to preclude. The corporation therefore says nothing about them, at this or at any later date, unless a subsequent aggregate crosses its own threshold.

What "declined" means

A declination at the template-class level means the Board is not prepared to authorise a client-facing procedure class of that shape at this time. It does not disallow the underlying research, and it does not preclude a differently-scoped proposal from being brought forward in future. A declined proposal may, at the discretion of its principal, be revised and resubmitted; the Board's practice, referenced obliquely in the charter, is that a substantively re-scoped resubmission is not treated as the same proposal for aggregate-count purposes, though a re-scoped proposal that is again declined is counted afresh.

None of the declined proposals have been or will be assigned a template name, a working code, or any other identifier that would permit external reference. Clients presently under structured follow-up on any of the four commercial Phenotype Renovations™ templates — Wolf, Otter, Vulpine, and Feline — are unaffected by the disclosure. No aspect of the corporation's safety register is altered by it.

The Board's own statement

“A veto is not a judgment on the science and it is not a judgment on the scientist. It is a judgment that, at this moment and on the evidence before the Board, the clinical form proposed is not one the corporation should offer to a client. That judgment is easier to make in some clades than in others. The Board takes no view, and expresses none, on whether a proposal it has declined this year would be declined again in ten.”

— Statement of the Chair of the Independent Ethics Board, released with the aggregate

Enquiries

The corporation will not entertain follow-up enquiries seeking to identify or characterise the individual proposals; such enquiries will be acknowledged but not answered. Institutional partners and regulators may obtain the redacted aggregate cover-sheet, in the form the Board itself signed off on, by writing to the Office of the General Counsel, 15 Sükhbaatar Square, Ulaanbaatar. The next aggregate disclosure will be made when, and only when, the charter's next threshold is crossed.

— ends —